Treatment outcome | Total MDR-TB | XDR-TB | Non-XDR-TB | χ2 | P |
---|---|---|---|---|---|
(N = 262), n (%) | (N = 18), n (%) | (N = 244), n (%) | |||
Treatment success (Cure, TC) | 145(55.34) | 6(33.33) | 139(56.97) | 3.789 | 0.052 |
Cure | 140(53.44) | 6(33.33) | 134(54.92) | 2.331 | 0.126 |
Completed | 5(1.91) | 0(0.00) | 5(2.05) | 0.078 | 0.779 |
Failure | 62(23.66) | 9(50.00) | 53(21.72) | 7.420 | 0.006 |
Death | 27(10.31) | 2(11.11) | 25(10.25) | 0.081 | 0.775 |
Default | 16(6.11) | 0(0.00) | 16(6.56) | 0.373 | 0.541 |
Transfer out | 12(4.58) | 1(5.56) | 11(4.51) | 0.143 | 0.704 |
Adverse drug reactions | 122 (46.55) | 7(38.89) | 115(47.13) | 0.458 | 0.499 |
GI upseta | 98(37.40) | 5(27.78) | 93(38.11) | 2.313 | 0.315 |
Hepatotoxicity | 36(13.74) | 1(5.56) | 35(14.34) | 5.522 | 0.063 |
Allergic reaction | 17(6.49) | 0(0.00) | 17(6.97) | 6.281 | 0.043 |
Neurologic abnormalities | 5(1.91) | 0(0.00) | 5(2.05) | 5.434 | 0.066 |
Mental disorder | 2(0.76) | 0(0.00) | 2(0.82) | 5.296 | 0.071 |
Hematologic abnormalities | 2(0.76) | 0(0.00) | 2(0.82) | 5.296 | 0.071 |
Electrolyte disturbances | 3(1.15) | 0(0.00) | 3(1.23) | 5.429 | 0.068 |
Renal toxicity | 5(1.91) | 0(0.00) | 5(2.05) | 5.434 | 0.066 |
Arthralgia or Courbature | 25(9.54) | 2(11.11) | 23(9.43) | 3.975 | 0.137 |
Hypothyroidism | 10(3.82) | 1(5.56) | 9(3.69) | 5.049 | 0.080 |